MADRIGAL PHARMACEUTICALS, INC. (MDGL) Deferred Tax Assets, Unrealized Losses on Trading Securities

MADRIGAL PHARMACEUTICALS, INC. Deferred Tax Assets, Unrealized Losses on Trading Securities

MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Deferred Tax Assets, Unrealized Losses on Trading Securities of $0 as of 2024-12-31, per its 10-K filed 2025-02-26.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsUnrealizedLossesOnTradingSecurities · last filed 2025-02-26

• 2024-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $0.00.
• 2023-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $0.00.
• 2022-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $8.00K.
• 2021-12-31: Deferred Tax Assets, Unrealized Losses on Trading Securities $23.00K.